Nameeta P. Richard

Hematology | Oncology
2801 N Gantenbein Ave Fl 3
Portland, OR 97227

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications

High risk of relapsed disease in patients with NK/T-cell chronic active Epstein-Barr virus disease outside of Asia.

High risk of relapsed disease in patients with NK/T-cell chronic active Epstein-Barr virus disease outside of Asia.

Journal: Blood advances
Published: May 17, 2021

Combined targeting of SET and tyrosine kinases provides an effective therapeutic approach in human T-cell acute lymphoblastic leukemia.

Combined targeting of SET and tyrosine kinases provides an effective therapeutic approach in human T-cell acute lymphoblastic leukemia.

Journal: Oncotarget
Published: February 26, 2016
Showing 1-2 of 2

Last Updated: 09/26/2026